| Literature DB >> 32443698 |
Carmine Buonocore1, Pietro Tedesco1,2, Giovanni Andrea Vitale1, Fortunato Palma Esposito3, Rosa Giugliano4, Maria Chiara Monti5, Maria Valeria D'Auria6, Donatella de Pascale1,3.
Abstract
Rhamnolipids (RLs) are surface-active molecules mainly produced by Pseudomonas spp. Antarctica is one of the less explored places on Earth and bioprospecting for novel RL producer strains represents a promising strategy for the discovery of novel structures. In the present study, 34 cultivable bacteria isolated from Edmonson Point Lake, Ross Sea, Antarctica were subjected to preliminary screening for the biosurfactant activity. The positive strains were identified by 16S rRNA gene sequencing and the produced RLs were characterized by liquid chromatography coupled to high resolution mass spectrometry (LC-HRESIMS) and liquid chromatography coupled with tandem spectrometry (LC-MS/MS), resulting in a new mixture of 17 different RL congeners, with six previously undescribed RLs. We explored the influence of the carbon source on the RL composition using 12 different raw materials, such as monosaccharides, polysaccharides and petroleum industry derivatives, reporting for the first time the production of RLs using, as sole carbon source, anthracene and benzene. Moreover, we investigated the antimicrobial potential of the RL mixture, towards a panel of both Gram-positive and Gram-negative pathogens, reporting very interesting results towards Listeria monocytogenes with a minimum inhibitory concentration (MIC) value of 3.13 µg/mL. Finally, we report for the first time the antimicrobial activity of RLs towards three strains of the emerging multidrug resistant Stenotrophomonas maltophilia with MIC values of 12.5 µg/ml.Entities:
Keywords: Antarctica; antimicrobials; bioprospecting; rhamnolipid
Mesh:
Substances:
Year: 2020 PMID: 32443698 PMCID: PMC7281774 DOI: 10.3390/md18050269
Source DB: PubMed Journal: Mar Drugs ISSN: 1660-3397 Impact factor: 5.118
Figure 1(a) Biosurfactants activity on a cetyltrimethylammonium bromide (CTAB) agar plate, the blue halos indicate the positivity to the test, the arrows show the positive extracts; (b) oil spreading test, the red arrows indicate the diameter of the halo; (c) the graph shows the E24 values of the tested supernatants and Tween 20®.
Figure 2Phylogenetic tree generated with MEGAX based on 16S rRNA gene sequences of M15, M38 and T28 strains and related species. Next to the branches are shown the percentage of replicate trees in which the associated taxa clustered together in the bootstrap test.
Figure 3Total ion chromatogram of: (a) M15 SPE 80% and (b) M15 SPE 100% fractions. The rhamnolipids (RLs) peaks are numerated and shown in Table 1.
Assignment of the identified RLs present in the LC-MS TICs of M15 80% and 100% fractions (Figure 3) a.
| No. | Retention Time (min) | Measured | Δ ppm | Molecular Formula | Key Fragment (Rha-FA1) | RL | n1 | n2 | Structure |
|---|---|---|---|---|---|---|---|---|---|
|
| 14.22 | 475.2779 | −26.9 | C24H44O9 | 305.1290 | Rha-C8-C10 | 1 | 3 |
|
|
| 16.76 | 489.3087 | +4.7 | C25H46O9 | 319.1520 | Rha-C9-C10 | 2 | 3 | |
|
| 17.21 | 501.2946 | −23.5 | C26H46O9 | 359.2195 | Rha-C12:1-C8 | 5(-2H) | 1 | |
|
| 19.38 | 503.3036 | −36.6 | C26H48O9 | 333.1660 | Rha-C10-C10 | 3 | 3 | |
|
| 21.12 | 517.3278 | −12.1 | C27H50O9 | 381.2199 | Rha-C11-C10 | 4 | 3 | |
|
| 23.00 | 529.3102 | −52.0 | C28H50O9 | 359.1872 | Rha-C12:1-C10 | 5(-2H) | 3 | |
|
| 24.75 | 531.3319 | −40.3 | C28H52O9 | 361.2039 | Rha-C12-C10 | 5 | 3 | |
|
| 25.26 | 555.3454 | −14.2 | C30H52O9 | 359.1942 | Rha-C12:1-C12:1 | 5(-2H) | 5(-2H) | |
|
| 26.63 | 557.3553 | −24.6 | C30H54O9 | 387.2223 | Rha-C14:1-C10 | 7(-2H) | 3 | |
|
| 27.17 | 557.3553 | −24.6 | C30H54O9 | 361.2039 | Rha-C12-C12:1 | 5 | 5(-2H) | |
|
| 27.94 | 557.3641 | −8.8 | C30H54O9 | 359.1872 | Rha-C12:1-C12 | 5(-2H) | 5 | |
|
| 29.52 | 583.3678 | −28.8 | C32H5609 | 387.2296 | Rha-C14:1-C12:1 | 7(-2H) | 5(-2H) | |
|
| 29.84 | 559.3688 | −28.2 | C30H56O9 | 389.2431 | Rha-C14-C10 | 7 | 3 | |
|
| 31.46 | 585.3919 | −14.3 | C32H5809 | 415.2556 | Rha-C16:1-C10 | 9(-2H) | 3 | |
|
| 32.20 | 585.3919 | −14.3 | C32H5809 | 387.2296 | Rha-C14:1-C12 | 7(-2H) | 5 | |
| Rha-C12-C14:1 | 5 | 7(-2H) | |||||||
|
| 35.85 | 587.4017 | −24.2 | C32H6009 | 417.2728 | Rha-C16-C10 | 9 | 3 |
a Rha denotes the a-L-rhamnopyranosyl moiety, the designation Cx means a fatty acid chain with chain length of X, Cx:1 means a fatty acid chain with chain length of X and with one unsaturated bond (–2H).
Figure 4The MS/MS spectra of the new RLs (a) Rha-C12:1-C8, (b) Rha-C12:1-C12:1, (c) Rha-C14:1-C12:1, and (d) Rha-C16:1-C10 confirmed their structure predicted on the basis of their in-source fragmentation. (e) The MS/MS spectra of the compound under the peak 15 showed the presence of the two RLs Rha-C14:1-C12 and Rha-C12-C14:1.
Relative abundance of the different rhamnolipid congeners in mixture detected in each growth condition.
| RL Relative Abundance (%) | ||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Carbon Source | 1 | 2 | 3 * | 4 | 5 | 6 | 7 | 8 * | 9 | 10 | 11 | 12 * | 13 | 14 * | 15 * | 16 |
|
| ||||||||||||||||
|
| 10.4 | 1.6 | 15.1 | 23.4 | 25.1 | 3.4 | 8.5 | 1.4 | 2.8 | 0.2 | 6.2 | 0.6 | 0.2 | 1.1 | ||
|
| 27.9 | 0.1 | 0.4 | 5.9 | 29.3 | 25.1 | 2.4 | 5.1 | 0.6 | 0.8 | 0.1 | 1.5 | 0.5 | 0.3 | ||
|
| 13.2 | 0.6 | 0.2 | 6.1 | 42.9 | 32.4 | 1.2 | 2.4 | 0.6 | 0.4 | ||||||
|
| ||||||||||||||||
|
| 29.6 | 9.2 | 36.4 | 19.8 | 0.6 | 2.6 | 0.2 | 0.3 | 0.9 | 0.4 | ||||||
|
| 18.9 | 9.7 | 50.1 | 18.8 | 0.9 | 1.6 | ||||||||||
|
| ||||||||||||||||
|
| 5.2 | 0.2 | 5.3 | 9.5 | 0.5 | 19.1 | 14.0 | 8.0 | 12.5 | 1.9 | 5.0 | 0.3 | 11.8 | 4.7 | 1.0 | 1.0 |
|
| 5.9 | 3.2 | 13.4 | 17.4 | 17.0 | 10.7 | 5.4 | 2.6 | 6.4 | 1.3 | 12.2 | 3.3 | 1.0 | 0.2 | ||
|
| ||||||||||||||||
|
| 24.1 | 0.3 | 0.2 | 6.4 | 37.3 | 25.5 | 2.0 | 2.0 | 0.3 | 0.6 | 1.3 | |||||
|
| 22.7 | 0.6 | 2.2 | 10.8 | 0.5 | 30.4 | 22.8 | 1.9 | 2.7 | 0.8 | 1.1 | 0.3 | 2.7 | 0.5 | ||
|
| ||||||||||||||||
|
| 4.6 | 9.0 | 1.2 | 28.4 | 50.2 | 1.0 | 2.1 | 0.3 | 0.6 | 2.4 | 0.2 | |||||
|
| 100.0 | |||||||||||||||
|
| ||||||||||||||||
|
| ||||||||||||||||
|
| 8.5 | 0.1 | 0.5 | 11.1 | 0.8 | 21.7 | 24.1 | 4.0 | 7.4 | 4.9 | 4.0 | 0.3 | 9.4 | 1.7 | 0.5 | 1.0 |
|
| 10.4 | 2.5 | 2.1 | 12.5 | 1.3 | 16.9 | 22.2 | 6.2 | 7.8 | 2.0 | 4.2 | 0.1 | 10.7 | 0.9 | 0.1 | 0.1 |
|
| 6.1 | 2.6 | 16.9 | 21.9 | 7.9 | 8.5 | 10.4 | 6.1 | 1.4 | 11.2 | 4.4 | 0.6 | 2.0 | |||
|
| ||||||||||||||||
* New RLs found in this study.
Antimicrobial activity of M15 MeOH fractions reported as minimum inhibitory concentration (MIC) value.
| Minimum Inhibitory Concentration (µg/mL) | |||||||
|---|---|---|---|---|---|---|---|
| Strains | Fractions | Strains | Fractions | ||||
| Gram-Positive | 60% | 80% | 100% | Gram-Negative | 60% | 80% | 100% |
|
| - | 6.25 | 3.13 |
| - | 12.5 | 25.0 |
|
| - | 25.0 | 12.5 |
| - | 12.5 | 12.5 |
|
| - | 12.5 | 25.0 |
| - | 12.5 | 25.0 |
|
| - | 12.5 | 12.5 |
| - | - | - |
|
| - | 25.0 | 25.0 |
| - | - | - |
|
| - | 50.0 | 100 |
| - | - | - |
|
| - | - | - |
| - | - | - |
|
| - | - | - | ||||
| - | - | - | |||||
| - | - | - | |||||
Antimicrobial activity of different growth conditions crude extracts reported as MIC values.
| Minimum Inhibitory Concentration (µg/mL) | |||||||
|---|---|---|---|---|---|---|---|
| Strains | Glucose | Mannose | Rhamnose | Glycerol | TYP | Xylan | Starch |
|
| |||||||
|
| 6.25 | 100 | - | 3.13 | 7.81 | - | - |
|
| 25.0 | - | - | 3.13 | 62.5 | - | - |
|
| 37.5 | 100 | - | 6.25 | 98.3 | - | - |
|
| - | - | - | 3.13 | 62.5 | - | - |
|
| |||||||
|
| 50.0 | - | - | 3.13 | 62.5 | - | - |